{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:26:41Z","timestamp":1787837201104,"version":"build-2784847793"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007]]},"DOI":"10.4103\/0022-3859.37525","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T01:27:10Z","timestamp":1235611630000},"page":"274-275","source":"Crossref","is-referenced-by-count":12,"title":["Risedronate induced transient ocular myasthenia"],"prefix":"10.4103","volume":"53","author":[{"given":"V","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sandanshiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20240205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1997.00440250045006","article-title":"Drugs and myasthenia gravis. An update","volume":"157","author":"Wittbrodt","year":"1997","journal-title":"Arch Intern Med"},{"key":"R2-18-20240205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0002-9394(00)00556-0","article-title":"Ocular myasthenia and nitrofurantoin","volume":"130","author":"Wasserman","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R3-18-20240205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/clinids\/22.1.175","article-title":"A clarithromycin-induced myasthenic syndrome","volume":"22","author":"Pijpers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R4-18-20240205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0404.1996.tb00055.x","article-title":"Myasthenia gravis and ciprofloxacin","volume":"94","author":"Roquer","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"R5-18-20240205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R6-18-20240205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/qjmed\/93.8.560","article-title":"Primary hyperthyroidism due to a parathyroid adenoma with subsequent myasthenia gravis","volume":"93","author":"Palin","year":"2000","journal-title":"QJM"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-200753040-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:18:21Z","timestamp":1787768301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-200753040-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.37525","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}